VERA peer analysis
Vera Therapeutics (VERA) against its competitors: price, today's move, 1-year return and market value side by side.
VERA and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| ACRS Aclaris Therapeutics | $3.90 | 8.03% | 59.73% | $504.77M |
| ALMS Alumis | $6.03 | 3.08% | 31.51% | – |
| ANAB AnaptysBio | $45.80 | 0.48% | 29.08% | $1.39B |
| ARQT Arcutis | $25.55 | -5.37% | 4.76% | $3.21B |
| BHVN Biohaven | $14.58 | 4.89% | 73.50% | $2.19B |
| DNTH Dianthus Therapeutics | $88.00 | 6.01% | 155.68% | – |
| KYTX Kyverna Therapeutics | $4.88 | 5.86% | -29.78% | – |
| MLTX MoonLake | $11.60 | 7.41% | 9.07% | – |
| PHAR Pharming Group | $12.30 | -1.28% | -6.54% | – |
| VERA Vera Therapeutics | $30.37 | 0.76% | 23.69% | – |
- VERA's peers: ACRS (Aclaris Therapeutics), ALMS (Alumis), ANAB (AnaptysBio), ARQT (Arcutis), BHVN (Biohaven), DNTH (Dianthus Therapeutics), KYTX (Kyverna Therapeutics), MLTX (MoonLake).
Updated 2026-11-07 11:55 UTC